Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...

加州大学旧金山分校药物化学家Brian Shoichet则质疑药企的数据量是否足以让AlphaFold实现重大突破。“他们能榨取的‘新意’可能有限，”但他也指出，即使预测药物与特定蛋白结合能力的准确率小幅提升（例如从实验室验证的20%成功率提高到50 ...

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

作者｜冬梅、核子可乐由 Demis Hassabis 领导的谷歌 AI 团队决定改变论文发布方法，意味着研究人员将更难对外公布成果。为了在蓬勃发展的 AI 行业中夺取主导地位、保持竞争优势，谷歌旗下 AI 部门 DeepMind ...